businessMar 26, 2025pending
Reading the Tea Leaves in FDA's AI-Enabled Device Guidelines
About this episode
While recent draft guidance from the Food and Drug Administration on artificial intelligence-enabled medical devices is non-binding, the document signals that the agency is intensifying its regulatory scrutiny of these technologies, said Dr. Scott Schell of IT consulting firm Cognizant.
Get every episode summarized
Each time Data Breach Today Podcast publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Data Breach Today Podcast
Why 'Emerging Threats' Are Harder to Prioritize in the AI Era
Data Breach Today Podcast
Mar 30, 2026failed
The End of Static Security: Why AI Demands Real-Time Microsegmentation
Data Breach Today Podcast
Mar 17, 2026failed
Why Data Security Standards in Cancer Innovation Matter
Data Breach Today Podcast
Mar 13, 2026failed
How Main Line Health Secures Devices With Microsegmentation
Data Breach Today Podcast
Mar 13, 2026failed